Media

Oncopeptides – Research shows that Pepaxti is effective in high-risk myeloma

Gesynta Pharma forms Scientific Advisory Board with international endometriosis experts

Vicore Pharma to move to the Nasdaq Stockholm Mid Cap segment

Clinical studies with Strangvac have begun in the U.S. market

Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors

The Neuron Clinic Launches New Alzheimer’s & Dementia Center Powered by Positrigo’s NeuroLF® Brain PET System

Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study

Vicore to present at the Oppenheimer Movers in Rare Disease Summit

HelloBetter launches Ello, a personal AI companion